class action lawsuit semaglutide Novo Nordisk expands lawsuits against weight-loss drug compounders Lawsuits claiming Ozempic, other GLP-1s

Description

While some of the warnings have changed over the last few years and and to some degree gotten better in the United States, said Jonathan Orent, a lead plaintiffs attorney with Motley Rice in the multidistrict litigation overseen by a federal court in Philadelphia, we think that the full panoply of conditions that this set of drugs can cause are not fully warned of, and until that happens, people are continuing to get hurt without having the full information. Some of the plaintiffs who spoke to USA TODAY said they hope to see stronger or more specific warnings about the potential for severe outcomes

The Global Market Landscape for GLP-1 Medications GLP-1 therapies are rapidly expanding in Europe, the Asia-Pacific region, including India and China, driven by rising obesity and supportive healthcare initiatives

Storage optimization guidance: Learn proper refrigeration techniques, how to identify quality bacteriostatic water, sterile reconstitution methods that prevent contamination, and travel storage solutions